Health
Nationwide Survey Underscores Concerns with Use of Topical Steroids and Need for Long-Term Treatment Strategies Facing the 46 Million Americans with Chronic Inflammatory Skin Conditions
Nearly 9 in 10 adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis being treated with topical steroids are concerned about side effectsNearly 8 in 10 adults and parents agreed that their or their child's treatment plan focuses on reactively “taming a flare” rather than proactive long-term solutionsWhen their skin condition is uncontrolled, nearly all adults and children experience emotional, mental, and daily life challenges WESTLAKE VILLAGE, Calif.
About this update from Arcutis Biotherapeutics, Inc.
[{"type":"image","alt":"Arcutis Biotherapeutics, Inc.","displaySize":"","headline":null,"caption":"Arcutis Biotherapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":54,"url":"https://media.zenfs.com/en/globenewswire.com/7ec1ad75d1b30c39742ed46c38e50fa3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ZXyX7hU4QA6ZJJZzELXH5w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc2O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/7ec1ad75d1b30c39742ed46c38e50fa3","width":300,"height":54}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Nearly 9 in 10 adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis being treated with topical steroids are concerned about side effects","length":182,"tagName":"p"}]},{"val":[{"type":"text","content":"Nearly 8 in 10 adults and parents agreed that their or their child's treatment plan focuses on reactively “taming a flare” rather than proactive long-term solutions","length":168,"tagName":"p"}]},{"val":[{"type":"text","content":"When their skin condition is uncontrolled, nearly all adults and children experience emotional, mental, and daily life challenges","length":129,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":479,"olType":false},{"type":"text","content":"WESTLAKE VILLAGE, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced results of Skin Insights: Steroid Perceptions in Chronic Inflammatory Skin Diseases, a nationwide survey of adults and parents of children with plaque psoriasis, atopic dermatitis (the most common form of eczema), and seborrheic dermatitis. The survey was designed to understand patient and parent perceptions and behaviors around the use of topical steroids, as well as perspectives on short-term, reactive treatments versus long-term, proactive disease management.","length":711,"tagName":"p"},{"type":"text","content":"“Psoriasis is a chronic disease that requires lifelong management — and much the same could be said of seborrheic dermatitis and eczema. This survey highlights an important trend: most treatment plans still focus on a reactive approach focused on taming flares, instead of a proactive, lon...